文献速递肾小球疾病遗传性与小管间质肾病

中性粒细胞在新月体性肾小球肾炎中的关键作用及新治疗靶点

Neutrophils are key mediators in crescentic glomerulonephritis and targets for new therapeutic approaches.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

本综述讨论中性粒细胞在新月体性肾小球肾炎(CGN)发病中的作用。中性粒细胞活化后产生活性氧、释放丝氨酸蛋白酶并形成中性粒细胞胞外诱捕网(NETs),可直接导致组织损伤;NETs上的髓过氧化物酶和蛋白酶3等可被加工为自身抗原,维持易感个体的自身免疫反应。靶向中性粒细胞脱颗粒和NETosis的新型化合物可能成为替代糖皮质激素的有前景的治疗选择。

要点

  • 中性粒细胞通过活性氧、丝氨酸蛋白酶和NETs直接损伤组织并参与CGN发病。
  • NETs上的髓过氧化物酶和蛋白酶3可成为自身抗原,驱动并维持自身免疫反应。
  • 靶向中性粒细胞脱颗粒和NETosis的新型化合物可能替代糖皮质激素治疗CGN。

核心结论

  • 中性粒细胞是新月体性肾小球肾炎发病的关键介质,靶向其脱颗粒和NETosis是有前景的新型治疗策略。

研究设计与样本

  • 本文为综述,基于实验数据讨论中性粒细胞在CGN发病中的作用及中性粒细胞脱颗粒和NETosis相关通路。

主要发现

  • 中性粒细胞活化后产生活性氧、释放丝氨酸蛋白酶并形成NETs,均可直接导致组织损伤。
  • NETs上呈现的髓过氧化物酶和蛋白酶3可被加工并识别为自身抗原,导致易感个体自身免疫反应的产生和维持。
  • 不同患者对NET蛋白自身免疫反应特异性的基础尚不清楚,但至少部分与人类白细胞抗原表达差异有关。
  • 与CGN相关的疾病常以中性粒细胞异常活化和NETosis为特征,部分还存在NET降解受损。

临床怎么用

  • 可使用多种新型化合物靶向中性粒细胞脱颗粒和NETosis,可能为CGN提供替代糖皮质激素的治疗选择。

局限性

  • 不同患者对NET蛋白自身免疫反应特异性的基础尚不清楚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Crescentic glomerulonephritis (CGN) results from a diverse set of diseases associated with immune dysregulation and the breakdown of self-tolerance to a wide range of autoantigens, some known and some that remain unknown. Experimental data demonstrate that neutrophils have an important role in the pathogenesis of CGN. Upon activation, neutrophils generate reactive oxygen species, release serine proteases and form neutrophil extracellular traps (NETs), all of which can induce direct tissue damage. In addition, serine proteases such as myeloperoxidase and proteinase 3, presented on NETs, can be processed and recognized as autoantigens, leading to the generation and maintenance of autoimmune responses in susceptible individuals. The basis of the specificity of autoimmune responses in different patients to NET proteins is unclear, but relates at least in part to differences in human leucocyte antigen expression. Conditions associated with CGN are often characterized by aberrant neutrophil activation and NETosis and, in some, impaired NET degradation. Targeting neutrophil degranulation and NETosis is now possible using a variety of novel compounds and may provide a promising therapeutic alternative to glucocorticoid use, which has been a mainstay of management in CGN for decades and is associated with significant adverse effects. In this review, we discuss the evidence supporting the role of neutrophils in the development of CGN and the pathways identified in neutrophil degranulation and NETosis that may translate to novel therapeutic applications.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Antonelou M, Evans RDR, Henderson SR, et al. Neutrophils are key mediators in crescentic glomerulonephritis and targets for new therapeutic approaches. Nephrol Dial Transplant. 2022. PMID: 33057680. doi:10.1093/ndt/gfaa206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。